Learn More
R&D Systems™ Human TGF-beta 1 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 240-B-001MG/CF
Description
Measured by its ability to inhibit the IL-4-dependent proliferation of HT-2 mouse T cells. Tsang, M. et al. (1995) Cytokine 7:389. The ED50 for this effect is 0.04-0.2 ng/mL. The specific activity of Recombinant Human TGF-beta 1 is approximately 2.5 x 104 U/μg, which is calibrated against human TGF-beta 1 Standard (NIBSC code: 89/514). Specific activity is for reference purposes only and is not routinely tested.Specifications
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA. | |
| 12.8 kDa (monomer) | |
| 1mg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 | |
| Yes |
| 7040 | |
| TGF-beta 1 | |
| Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Ala279-Ser390 | |
| Disulfide-linked homodimer | |
| Unconjugated |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.